Close

Seattle Genetics (SGEN) Commences Tender Offer for Cascadian Therapeutics (CASC)

February 8, 2018 5:43 PM EST Send to a Friend
Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that its wholly-owned subsidiary, Valley Acquisition Sub, Inc., has commenced its previously announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login